To Be Precise

Medical institutions across the US are investing in large centers, new technology, and more experts to bring precision medicine — the new personalized medicine — to the clinic, especially to cancer patients, the New York Times reports. While the expectation is that, eventually, every patient will undergo genomic sequencing, "even optimists warn that medicine is a long way from deriving useful information from routine sequencing," the Times says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.